GENUV

vaccines, adjuvants for use with vaccines, pharmaceutical preparations for veterinary use, for the treatment of cancer, autoimmune diseases, infectious diseases and neurodegenerative diseases; pharmaceutical preparations for the treatment of cancer, biological and chemical reagents for medical or veterinary purposes, nucleic acid sequences for medical and veterinary purposes, biotechnological preparations for medical purposes for the treatment of cancer, autoimmune diseases, infectious diseases and neurodegenerative diseases, biological preparations for medical purposes for the treatment of cancer, autoimmune diseases, infectious diseases and neurodegenerative diseases, living cells for medical purposes, pharmaceutical preparations for the treatment of infectious diseases and neurodegenerative diseases, pharmaceutical preparations for the treatment of autoimmune diseases, pharmaceutical preparations for the treatment of central nervous system diseases, diagnostic antibodies for use in disease testing, preparations, namely, cultures of microorganisms for medical or veterinary use, implants comprising living tissue